Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	23.20B +4.1%
Revenue (ttm)	8.71B -6.8%
Net Income	468.07M -58.9%
EPS	0.32 -59.0%
Shares Out	1.49B
PE Ratio	48.78
Forward PE	27.80
Dividend	0.25 (1.58%)
Ex-Dividend Date	Jul 10, 2025

Volume	13,289,856
Average Volume	14,657,580
Open	15.55
Previous Close	15.57
Day's Range	15.30 - 15.84
52-Week Range	13.49 - 27.97
Beta	0.20
RSI	38.00
Earnings Date	Apr 30, 2026

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade serv...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 9,065
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2024, SHA:600521's revenue was 9.55 billion, an increase of 14.91% compared to the previous year's 8.31 billion. Earnings were 1.12 billion, an increase of 34.74%.